Archive for the ‘strategy’ Category

This is Part II of the analysis on pharma’s twitter presence. If you remember, we saw in part I that some pharma companies seem to be more engaged than others on twitter.
Based on visualizing the basic twitter statistics (followers, following and updates), we came to the conclusion that Boehringer Ingelheim, Johnson & Johnson and Roche were leading [...]

Upon popular demand, I decided to kick off this year with an update of my Pharma twittersphere analysis. In this analysis I will compare how many people follow the pharmacos’ twitter accounts (followers), how many people pharmacos’ follow back (following) and the number of times the account is updated  (updates). I will also observe how [...]

The FDA hearing on social media took place almost a month ago already and a lof of ink (or pixel for that matter) has flown since on what was presented. I vividly encourage you to dig through the sources on Fabio Gratton’s excellent #fdasm site to paint your own picture of the content.
In my simplitic [...]

Researching the latest EU commission view point on social media, I came across this very upsetting conclusion from a review on the state of patient information in Europe:

Today huge inequalities exist in terms of availability and accessibility of information between different population groups and between EU member states.
Health related websites are amongst most frequently visited [...]

Andrew Spong from STweM and I had a great discussion about the state of the European social media landscape in healthcare at the beginning of this week. We realized a couple of interesting things:
1.We had both gathered a lot of interesting bits and pieces concerning national advances in social media and healthcare, but we were [...]

Lately, I witnessed the start of a fascinating dialog between pharma, medical device companies and diabetes bloggers. Roche, for example, just sponsored the first diabetes blog summit bringing together the most influential diabetes bloggers and online community leaders, in order to identify avenues for collaboration. zw4qg6bvya
TuDiabetes, a diabetes online community of over 10,000 members, has [...]

A fascinating discussion popped-up today around strategies and tactics that pharma should use to engage with social media.
Johnathan over at dose of digital started this discussion with this list of interesting tactics that pharma should explore. He got fed up with pharma shuffeling their feet not daring to dip their toe into the cold, rough [...]


About this blog

The Internet holds the power to profoundly change the way healthcare is delivered. Millions of patients, caregivers and physicians turn to the Internet every day to look up the latest information on important health topics and find support from like-minded people.

Continue reading...

  • Kwai Yu: Hi Silja, Cherie sent me a quick note about you ... no wonder she said you were amazing :-) I [...]
  • Evaluating Pharmaceutical Twitter Accounts | PRforPharma: [...] compare to so-called best practices for Twitter engagement.  WhyDotPharma has already conduct [...]
  • Tammy: I enjoyed your posting. Especially the part about the, BOGSAT’s syndrom: Bunch Of Guys Sitting Aro [...]
  • Sabine: Hi Silja, my guess is: about 5 Mio Very interesting and helpful findings there - curious to se [...]
  • R.J. Lewis: Nice analysis! Nice to see someone is tracking pharma's activity. Perhaps you should set up an ann [...]

whydotpharma